For people living with Crohn’s disease, life can feel like a constant battle against their own body. For decades, scientists have searched for the reason why the immune system suddenly turns on the gut — and now, artificial intelligence may have revealed the answer.
When the body’s balance breaks
A research team at the University of California San Diego (UCSD) used AI to explore how immune cells in the gut decide whether to trigger inflammation or begin healing.
Their discovery points to a crucial partnership between two proteins — NOD2 and girdin — that must work together to keep the gut’s immune system stable.
When that connection fails, the immune system loses control and chronic inflammation takes over.
Also read: New study finds no link between Covid-19 vaccines and long-term symptoms
This imbalance is at the heart of Crohn’s disease, which affects millions of people worldwide.
A genetic glitch with big consequences
Through advanced machine learning, the scientists analyzed thousands of gene profiles from intestinal tissue.
The AI identified 53 genes that separate harmful inflammatory cells from the restorative ones. One of those genes, which produces the girdin protein, turned out to be central.
In healthy individuals, NOD2 binds to girdin to control inflammation. But in people with Crohn’s, a common mutation in NOD2 removes the spot where girdin normally connects.
Also read: Study finds link between children’s screen time and early heart risk factors
Without that link, the immune system can’t regulate itself — and inflammation spirals out of control.
Testing the theory in mice
To verify the results, researchers bred mice lacking the girdin protein. These animals quickly developed severe intestinal inflammation and major changes in their gut microbiome — just like Crohn’s patients. Mice that still had girdin stayed healthy.
This confirms that the NOD2–girdin partnership acts like an immune “switch” that determines whether the body heals or attacks itself.
New hope for treatment
The findings give scientists a new target for therapy. If doctors can restore the missing connection between NOD2 and girdin, it might be possible to stop inflammation at its source — not just treat the symptoms.
Also read: Why sighing is essential for both body and mind
Researchers believe AI will soon help personalize treatments based on each patient’s genetic and immune profile, improving outcomes and potentially preventing the disease from progressing.
The study, published in The Journal of Clinical Investigation, marks a major breakthrough in understanding a condition that has puzzled medicine for more than 25 years.
Also read: Scientists confirm: Oral hygiene plays a key role in heart disease prevention